FDA may ease warning on hormone therapy for menopause symptoms

The U.S. Food and Drug Administration (FDA) is reviewing whether to change the warning label on hormone replacement therapy (HRT) drugs used to treat menopause symptoms, a move many experts say is long overdue.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup